BMO Capital upgraded Omega Healthcare (OHI) to Outperform from Market Perform with an unchanged price target of $45. The firm expects continued “robust” accretive acquisitions from Omega with its estimates modestly above the Street. The company has a strong balance sheet to drive earnings while its diversified tenant base “limits idiosyncratic credit risk,” the analyst tells investors in a research note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OHI:
- Omega Healthcare price target raised to $37 from $35 at Mizuho
- Omega Healthcare price target raised to $43 from $39 at BofA
- Omega Healthcare price target raised to $43 from $39 at RBC Capital
- Omega Healthcare Investors Shows Strong Q3 Performance
- Omega Healthcare upgraded to Outperform from Neutral at Exane BNP Paribas
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
